Atria Investments LLC Boosts Holdings in Cognex Co. (CGNX)
Atria Investments LLC boosted its position in shares of Cognex Co. (NASDAQ:CGNX) by 62.3% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 7,648 shares of the scientific and technical instruments company’s stock after purchasing an additional 2,935 shares during the quarter. Atria Investments LLC’s holdings in Cognex were worth $468,000 at the end of the most recent quarter.
Other large investors have also recently bought and sold shares of the company. Nisa Investment Advisors LLC lifted its stake in shares of Cognex by 100.0% in the 4th quarter. Nisa Investment Advisors LLC now owns 21,900 shares of the scientific and technical instruments company’s stock valued at $1,339,000 after purchasing an additional 10,950 shares during the period. Jaffetilchin Investment Partners LLC lifted its stake in shares of Cognex by 79.8% in the 4th quarter. Jaffetilchin Investment Partners LLC now owns 8,246 shares of the scientific and technical instruments company’s stock valued at $504,000 after purchasing an additional 3,660 shares during the period. Sit Investment Associates Inc. acquired a new position in shares of Cognex in the 4th quarter valued at $985,000. DnB Asset Management AS acquired a new position in shares of Cognex in the 4th quarter valued at $838,000. Finally, Parametric Portfolio Associates LLC lifted its stake in shares of Cognex by 19.9% in the 3rd quarter. Parametric Portfolio Associates LLC now owns 124,168 shares of the scientific and technical instruments company’s stock valued at $13,693,000 after purchasing an additional 20,615 shares during the period. 42.25% of the stock is currently owned by hedge funds and other institutional investors.
A number of research firms have recently weighed in on CGNX. BidaskClub downgraded Cognex from a “buy” rating to a “hold” rating in a research note on Thursday, December 7th. Canaccord Genuity increased their price target on Cognex from $47.50 to $60.00 and gave the company a “hold” rating in a research note on Tuesday, October 31st. Deutsche Bank set a $80.00 price target on Cognex and gave the company a “buy” rating in a research note on Friday, January 19th. Robert W. Baird raised their price objective on Cognex from $50.00 to $62.00 and gave the stock a “neutral” rating in a research note on Tuesday, October 31st. Finally, ValuEngine downgraded Cognex from a “hold” rating to a “sell” rating in a research note on Thursday, December 7th. Three research analysts have rated the stock with a sell rating, three have issued a hold rating and six have given a buy rating to the company’s stock. Cognex has a consensus rating of “Hold” and a consensus price target of $63.00.
Cognex (NASDAQ:CGNX) last issued its quarterly earnings data on Monday, October 30th. The scientific and technical instruments company reported $0.57 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.52 by $0.05. The business had revenue of $259.74 million for the quarter, compared to the consensus estimate of $255.95 million. Cognex had a return on equity of 23.31% and a net margin of 34.77%. The firm’s revenue was up 75.6% compared to the same quarter last year. During the same quarter last year, the business posted $0.31 EPS. equities research analysts predict that Cognex Co. will post 1.39 earnings per share for the current year.
In other Cognex news, CEO Robert Willett sold 100,000 shares of the stock in a transaction dated Thursday, November 2nd. The stock was sold at an average price of $127.19, for a total transaction of $12,719,000.00. Following the completion of the transaction, the chief executive officer now owns 100,000 shares in the company, valued at approximately $12,719,000. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Jeffrey Benjamin Miller sold 3,750 shares of the stock in a transaction dated Monday, November 6th. The stock was sold at an average price of $134.48, for a total value of $504,300.00. Following the transaction, the director now owns 3,750 shares of the company’s stock, valued at approximately $504,300. The disclosure for this sale can be found here. Insiders have sold a total of 143,750 shares of company stock worth $18,540,975 in the last ninety days. 5.60% of the stock is currently owned by company insiders.
COPYRIGHT VIOLATION WARNING: “Atria Investments LLC Boosts Holdings in Cognex Co. (CGNX)” was posted by TheOlympiaReport and is the property of of TheOlympiaReport. If you are reading this news story on another website, it was copied illegally and republished in violation of U.S. and international trademark & copyright legislation. The legal version of this news story can be read at https://theolympiareport.com/2018/01/24/atria-investments-llc-boosts-holdings-in-cognex-co-cgnx.html.
Cognex Corporation (Cognex) is a provider of machine vision products that capture and analyze visual information in order to automate tasks, primarily in manufacturing processes, where vision is required. The Company operates through the machine vision technology segment. The Company’s machine vision products are used to automate the manufacture and tracking of discrete items, such as mobile phones, aspirin bottles and automobile tires, by locating, identifying, inspecting and measuring them during the manufacturing or distribution process.
Want to see what other hedge funds are holding CGNX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cognex Co. (NASDAQ:CGNX).
Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.